Table 2 of Yang, Mol Vis 2011; 17:2655-2664.
Polymorphism
|
Female AU patients (n=53) |
Female controls (n=183) |
p-value |
Odds ratio (95% confidence interval) |
---|---|---|---|---|
rs800292 (CFH 184G/A) | ||||
Genotype | ||||
AA | 3 (5.7) | 31 (16.9) | 0.015§ | |
AG | 19 (35.8) | 82 (44.8) | 0.009* | 2.28 (1.22–4.24) |
GG | 31 (58.5) | 70 (38.3) | 0.039‡ | 3.40 (1.00–11.6) |
Allele | ||||
A | 25 (23.6) | 144 (39.3) | 0.003§ | 2.10 (1.28–3.45) |
G | 81 (76.4) | 222 (60.7) | ||
rs4505848 (KIAA1109 G/A) | ||||
Genotype | ||||
GG | 7 (13.2) | 27 (14.8) | 0.54§ | |
AG | 32 (60.4) | 95 (51.9) | ||
AA | 14 (26.4) | 61 (33.3) | ||
Allele | ||||
G | 46 (43.4) | 149 (40.7) | 0.62§ | |
A | 60 (56.6) | 217 (59.3) | ||
rs4788084 (IL27 T/C) | ||||
Genotype | ||||
TT | 8 (15.1) | 12 (6.6) | 0.13§ | |
CT | 19 (35.8) | 78 (42.6) | ||
CC | 26 (49.1) | 93 (50.8) | ||
Allele | ||||
T | 35 (33.0) | 102 (27.9) | 0.30§ | |
C | 71 (67.0) | 264 (72.1) |